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ABSTRACT 
 
 
Leukocyte-specific protein 1 (LSP1) is an intracellular, F-actin- and Ca2+-binding, 
phosphoprotein expressed in leukocytes and endothelial cells (ECs). It is important in leukocyte 
motility and recruitment during inflammation. The role of LSP1 and its signaling mechanisms in 
chemokine-induced neutrophil transendothelial recruitment are not well understood. In this study, 
the role of neutrophil LSP1 (N-LSP1) and endothelial LSP1 (E-LSP1) in neutrophil-endothelial 
cell interactions in the post-capillary venules was investigated by using intravital microscopy and 
time-lapse video photography. This was determined in response to two very similar CXC 
chemokines keratinocyte-derived chemokine (KC, CXCL1) and macrophage inflammatory 
protein-2 (MIP-2, CXCL2). To induce neutrophil recruitment, one mm3  piece of agarose gel 
containing MIP-2 or KC was carefully placed on 350 μm from the observed post-capillary venule 
of the mouse cremaster muscle. Neutrophil intraluminal crawling, transmigration, and chemotaxis 
in the muscle were analyzed by the use of LSP1-deficient (Lsp1−/−) mice, wild-type (WT) 129/SvJ 
mice and their four types of chimeric mice (Lsp1−/−→Lsp1−/−, WT→Lsp1−/−, Lsp1−/−→WT and 
WT→WT)*. We observed that Lsp1−/− mice exhibited similar responses to MIP-2 or KC-induced 
neutrophil recruitment compared to the WT mice. Emigration in neutrophil recruitment was 
significantly inhibited in Lsp1−/− mice. Neutrophils in Lsp1−/− mice, compared to those in the WT 
mice, displayed longer crawling time, slower crawling velocities and had lower chemotaxis index 
during their intraluminal crawling in venules in response to MIP-2. The transmigration time of 
 
 
Lsp1−/− neutrophils was longer than that of WT neutrophils, although LSP1 did not appear to play 
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a role during neutrophil detachment from endothelium in response to MIP-2. Substantial defects 
were observed in Lsp1−/− neutrophils during their chemotaxis in muscle tissue in response to 
MIP-2. For dissecting the role of LSP1 in neutrophils and ECs, we repeated these experiments 
using chimeric mice. We found that neutrophil emigration was significantly inhibited in 
WT→Lsp1−/− mice as well as in Lsp1−/−→Lsp1−/− mice but not in Lsp1−/−→WT mice or 
WT→WT mice. N-LSP1 promoted intraluminal crawling and transmigration while E-LSP1 
played more important roles in MIP-2-induced neutrophil transmigration and chemotaxis in tissue. 
In addition, p38 mitogen-activated protein kinase (MAPK) inhibitor SKF86002 abolished 
neutrophil recruitment and chemotaxis in tissue of WT mice. These inhibitory effects were 
partially achieved through LSP1 in MIP-2-induced neutrophil recruitment. 
 
 
Taken together, these results suggest that both N-LSP1 and E-LSP1 are important in 
 
 
MIP-2-induced neutrophil intraluminal crawling and neutrophil transendothelial migration. These 
results also suggest that E-LSP1 may have a more important role in neutrophil transendothelial 
migration and in neutrophil chemotaxis both in the lumen and in extravascular tissues as well. 
Additionally, they demonstrate that MIP-2-induced neutrophil recruitment and chemotaxis in 
tissue is dependent on p38 MAPK activation. 
*, Four types of LSP1 chimeric mice were generated; Lsp1−/− mice reconstituted with Lsp1−/− 
neutrophils and WT neutrophils were indicated as Lsp1−/−→Lsp1−/− and WT→Lsp1−/−, 
respectively, and WT mice reconstituted with Lsp1−/− and WT neutrophils were indicated as 
Lsp1−/−→WT and WT→WT, respectively. 
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 1. Introduction 
 
 
 
1.1. Neutrophil Recruitment during Inflammatory Response in vivo 
 
 
 
Neutrophils, a subtype of leukocytes, are generally referred to polymorphonuclear leukocytes 
(PMNs). The endothelium is a thin and smooth layer of endothelial cells (ECs) which form the 
interface between circulating blood and the extravascular tissue. During acute inflammation, 
neutrophils in blood stream interact with vascular ECs and migrate towards the site of 
inflammation. This process is called neutrophil recruitment, which is the movement of 
circulating neutrophils from the blood stream to the inflamed site, and is a complex but crucial 
process for the development and outcome of inflammation. The current view of this process 
depicts a series of sequential steps that include neutrophils tethering and rolling, adhesion, 
intraluminal crawling on the luminal walls of the post-capillary venules, transendothelial 
migration (TEM) across the venules and migration in extravascular tissues to the inflamed site 
[1]. The process also involves many molecules such as selectins, integrins and the coordination 
of their cellular functions to induce directed cell movements. Fig. 1.1 presents a brief and 
schematic view of neutrophil recruitment process. 
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Fig. 1.1 The process of neutrophil recruitment during the interactions between neutrophils 
and ECs at post-capillary venules in cremasteric or mesenteric microvasculature. (Modified from 
Reference 1) 
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1.1.1. Neutrophil tethering, rolling and adhesion 
 
 
 
The multistep process of neutrophil recruitment is initiated by neutrophil tethering and rolling 
on the endothelial lining of the post-capillary venules. The rolling of neutrophils is mediated by 
the selectin family adhesion molecules which include P-selectin, E-selectin and L-selectin, and, 
in some cases by α4-integrin, as well as their ligands [1]. P-selectins are expressed on the 
luminal surface of activated ECs and activated platelets. E-selectins are exclusively expressed on 
 
 
activated ECs such as those activated by cytokines, for example, interleukin (IL)-1 or tumor 
necrosis factor-α (TNF-α), whereas L-selectins are expressed only on leukocytes. In addition, it 
has been reported that the β2 integrin lymphocyte function-associated antigen 1 (LFA-1, 
CD11a/CD18, αLβ2 integrin) is also involved in rolling step [2]. This step localizes neutrophils to 
the endothelial surface to sense chemokines and other chemoattractants on the venular surface. 
 
 
 
The following step is neutrophil adhesion. In response to chemokines on the luminal surface 
of the endothelium, the rolling neutrophils are activated and arrested on the endothelium by the 
modulation of integrins such as α4-integrin and β2 integrin and the binding to their ligands. 
During firm adhesion, neutrophils spread, flatten and form the focal adhesion-like structures. 
 
 
These structures consist of high affinity integrins which interact with their ligands such as 
intercellular adhesion molecule-1 (ICAM-1) or vascular cell adhesion molecule-1 (VCAM-1) [1]. 
It has been reported that the β2 integrin LFA-1 (αLβ2) plays a dominant role during the neutrophil 
adhesion step [2, 3]. In addition, shear flow is another important factor to induce adhesion. 
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Under sheer flow, adhesion can be enhanced even if the activity of β2 integrin is low in the 
presence of chemokines [4]. 
 
 
 
 
 
 
1.1.2. Neutrophil intraluminal crawling 
 
 
 
Following adhesion is an important, recently identified step called intraluminal crawling. 
Intraluminal crawling means that many adhering neutrophils move from the initial adherent sites 
to the junctional extravasation sites on the endothelium in response to exogenous or endogenous 
chemokines or other chemoattractants in vivo [3]. In fact, this process appears to direct the cell to 
reach optimal emigration sites at endothelial junctions. In this step, neutrophils interact with ECs 
to accomplish cell morphological changes and motility. Reports showed that adhesion is mainly 
regulated by LFA-1 whereas intraluminal crawling is mediated by the β2 integrin macrophage 
antigen 1 (Mac-1, CD11b/CD18, αMβ2 integrin) [3]. In the presence of chemoattractant in the 
 
 
extravascular environment, a chemoattractant gradient exists in the lumen and the crawling cells 
undergo chemotaxis in the lumen towards chemoattractant [5]. This neutrophil-endothelial cell 
interaction effectively promotes subsequent transendothelial migration. When the intraluminal 
crawling is disabled, neutrophil transmigration will be delayed and the transmigration route will 
be changed to mainly transcellular pathway instead of the predominant paracellular pathway [3]. 
In order to migrate, cells extend flat, filamentous (F)-actin-rich sheet-like structures (called 
lamellipodia) and thin, needle-like projections (called filopodia) from their leading edge and 
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attach to the extracellular substrate, while contracting their trailing edge to detach from the rear 
[6]. As a result, F-actin is polymerized and the cell moves the bulk of the cytoplasm and the 
nucleus forward [7-10]. In addition, F-actin filaments are bundled in filopodia and crosslinked in 
lamellipodia [6], and the podosome-like protrusions invaginate the endothelium to promote cell 
migration [11]. 
 
 
 
 
 
 
1.1.3. Neutrophil transendothelial migration 
 
 
 
Transendothelial migration (TEM) is an intricate and very dynamic neutrophil-endothelial cell 
interaction process. Emigrating neutrophils encounter three distinct barriers: ECs, the 
endothelial-cell basement membrane, and pericytes. There are two transmigration routes, 
paracellular and transcellular pathways. The paracellular pathway means neutrophils 
transmigrate through endothelial junctions whereas the transcellular pathway means neutrophils 
transmigrate through the cell body of the endothelium. Neutrophils can switch from one to the 
other relying on the environmental conditions. For example, paracellular TEM can be shifted to 
transcellular TEM when certain adhesion molecules including Mac-1 or ICAM-1 are inhibited 
[12]. However, paracellular transmigration is the predominant route taken by neutrophils, since 
more than 90% of the transmigratory events are observed to take place in close proximity to 
endothelial cell junctions [3]. Cell motility is initiated by signaling transduction and involves lots 
 
 
of molecules both on neutrophils and endothelium such as LFA-1 and Mac-1 integrins and 
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endothelial cell-selective adhesion molecule (ESAM) as well as their ligands [13]. The process 
of TEM is very complex. Neutrophil TEM by paracellular or transcellular route is illustrated in 
Fig.1.2 below. 
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Fig. 1.2 The mechanisms of neutrophil transendothelial migration. (a) Under shear flow, 
crawling neutrophils with podosome-like protrusions invaginate into the endothelium. 
Endothelial-cell junctions are activated by the binding of integrins and their ligands (e.g. , 
ICAM-1 and Mac-1). Once activated, the increased EC intracellular Ca2+ leads to the activation 
of p38 mitogen-activated protein kinase (MAPK), which finally induces EC contractions and 
inter-endothelial contacts opening to promote neutrophil paracellular or transcellular migration 
[14, 15]. (b) Paracellular migration involves a lot of endothelial-cell junctional molecules, such 
as junctional adhesion molecule A (JAM-A), platelet/endothelial-cell adhesion molecule 1 
(PECAM-1), ICAM-1/2, CD99. JAM-A, PECAM-1 and ESAM, which regulate the release of 
endothelial-expressed vascular endothelial cadherin (VE-cadherin) by activating different 
signaling pathways, induce endothelial cell contraction, permeability changes and facilitate 
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neutrophil transmigration [14, 16, 17]. (c) Transcellular migration occurs in areas of 
endothelial-cell thinning, so that the neutrophils only cross small distances [18]. Ligation of 
ICAM-1 leads to the transportation of ICAM-1 with caveolin-1 to the basal plasma membrane 
which results in the formation of vesiculo-vacuolar organelles (VVOs) that establish an 
intracellular channel channels in endothelium to promote the neutrophil transmigration [4, 19]. 
(Modified from Reference 13) 
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However, the endothelium is critically important in the transmigration step no matter which 
transmigration routes neutrophils use. During transendothelial migration, the endothelium forms 
docking structures (also known as transmigration cups) around adherent neutrophils which 
extend pseudopodia to facilitate neutrophil migration [11]. These structures strongly express 
integrins such as LFA-1 as well as their ligands (e.g. ICAM-1 and VCAM-1), and they allow 
very close contact between neutrophils and the endothelium [20, 21]. ICAM-1 and VCAM-1 
connect to the actin-cytoskeleton through the adaptor proteins such as ERM (ezrin, radixin and 
moesin) [22]. The interactions of integrins with their ligands lead to the reorganization of the 
cytoskeleton by anchorage of adaptor proteins with α-actinin and vinculin [23]. In addition, an 
amazing observation is the dome structure that was observed in vivo (Fig. 1.3). Before 
neutrophils migrate out of the endothelium, the involving endothelial cell extends its cell body 
and envelopes the whole adherent neutrophils by the formation of dome structure without any 
disruptions of endothelium [11]. The dome–like encapsulations develop from the docking 
structures [11]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.3 The novel "dome"-like structures (arrows) in vivo. This electron microscopy picture 
shows the formation of the “dome”-like structure surrounding a transmigrating neutrophil. 
Abbreviations: e, endothelial cell; n, neutrophil; L, lumen. (Modified from Reference 1) 
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1.1.4. Neutrophil chemotaxis in tissue 
 
 
 
The ability of cells to sense external chemokines or other chemoattractants and to respond by 
directionally migrating towards them, is a fundamental process called chemotaxis [24]. 
Chemoattractants are derived from the endogenous host cells such as ECs, macrophages and 
neutrophils, or from exogenous bacteria components such as 
formyl-methionyl-leucyl-phenylalanine (fMLP). After migration across the endothelium barrier, 
neutrophils reach the extravascular tissues and undergo chemotaxis. Neutrophil chemotaxis is a 
dynamic process including directional sensing, signaling transduction, cell polarization, cell 
adhesion and motility [25]. It is initiated by neutrophil sensing a chemoattractant gradient in its 
extravasular environment via tyrosine kinase receptors and G protein-coupled receptors [26-28]. 
Chemotaxing neutrophils have an amazing ability to detect small changes in the concentration of a 
chemoattractant and can amplify their responses to very subtle chemoattractant gradients [25]. After 
sensing the chemoattractant gradient, neutrophils undergo polarization by the activation of spatially 
localized cellular signals. The polarized cell has well-defined leading lamellipodia or filopodia 
which are filled with F-actin and extend towards the chemoattractant, and a trailing ‘‘tail’’, called a 
uropod, which is filled with actin filament and myosin II complexes to control uropod movement 
and promote the tail contraction (Fig. 1.4). By the regulation of dynamic signaling interactions 
between the front and the back of chemotaxing cells, neutrophils translocate their bodies forward 
and detach from the adhesion sites [27]. 
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Fig. 1.4 The model for the formation of an activation domain in chemotaxing cells. 
Chemoattractant receptors, G-protein coupled receptors (GPCRs), are uniformly distributed around 
the cell membrane. On sensing a chemoattractant gradient, the activated phosphatidylinoside 
3-kinase (PI3K) in the membrane closest to the chemoattractant source stimulates 
phosphatidylinositol (3,4,5) trisphosphate (PIP3) production [29]. The external chemoattractant 
gradient is amplified internally via positive feedback loops of PIP3 production at the front of cells 
(indicated by ‘+’), in combination with inhibition of pathways by dephosphorylation of PIP3 along 
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the trailing edges of the cells (indicated by ‘–’) [29]. Multiple signaling molecules are preferentially 
localized at the leading edge, such as protein kinase B (Akt/PKB), cell division control protein 42 
homolog (Cdc42), Wiskott–Aldrich syndrome protein (WASP), to produce an activation domain 
including PH-domain proteins [27]. F-actin localizes at the leading edge to induce protrusion of 
pseudopodia following the activation of small GTPases (Rac1/Cdc42) and their downstream 
effectors, including WASP, myosin I kinase and PAK1 in mammalian cells [27, 30]. Once activated, 
actin undergoes polymerization and induces cytoskeletal remodeling which results in cell protrusion, 
adhesion, de-adhesion and forward movement [27]. Myosin II is assembled at the trailing edges and 
lateral sides of cell. The main functions of myosin II provide rigidity to the polarized cells, helping 
uropod de-adhesion to the substrate and retraction in line with the chemoattractant gradient [27]. 
Abbreviations: Akt/PKB, protein kinase B; Cdc42, cell division control protein 42 homolog; F-actin, 
filamentous actin; PAK, p21-activated kinase; PH, pleckstrin homology; PI3K, phosphatidylinoside 
3-kinase; PIP3, phosphatidylinositol (3,4,5) trisphosphate; WASP, Wiskott–Aldrich syndrome 
 
 
protein. (Modified from Reference 27) 
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1.2. Chemokines 
 
 
 
Chemokines are a family of small 67-127 amino acid chemotactic cytokines that are either 
secreted or membrane-bound. Chemokines are chemoattractants and their major role is to induce 
cell chemotaxis. There are four subfamilies: CXC, CC, C, and CX3C according to the spacing of 
their first two cysteine residues [31, 32]. The N-terminus of chemokines is important for their 
interactions with neutrophil chemokine receptors whereas the C-terminus has a high affinity for 
glycosaminoglycans (GAGs) and other negatively charged sugar moieties [33]. Chemokines induce 
signal transduction via binding to chemokine receptors. Chemokine receptors are a group of 
seven-transmembrane G-protein coupled cell membrane receptors (GPCRs) and divided into four 
subtypes (CXCR, CCR, CR and CX3CR) based on the four chemokine subfamilies [33]. 
Chemokines function at all stages of neutrophil recruitment. During the process of neutrophil 
 
 
recruitment, chemokines must be immobilized on the venular lumen under shear flow to trigger 
rolling neutrophils to adhere [34]. Many chemokines can be immobilized on ECs via binding to 
GAGs and others can be co-immobilized with selectin ligands or integrin ligands [35]. It has been 
reported that chemokines are important for neutrophil adhesion by increasing the affinity of 
integrins [36-38]. A number of signaling pathways within neutrophils and the endothelium are 
involved in chemokine-induced transendothelial migration. It has been reported that CXC 
chemokine keratinocyte-derived chemokine (KC)-induced neutrophil recruitment in vivo is p38 
MAPK signaling pathway-dependent [39]. In addition, it has been demonstrated that CXC 
 
 
chemokine KC and macrophage inflammatory protein-2 (MIP-2)-induced neutrophil recruitment is 
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eliminated by treating with a p38 MAPK inhibitor in vitro [40]. 
 
 
 
 
 
1.3. Leukocyte-specific protein 1 (LSP1) 
 
 
 
Leukocyte-specific protein 1 (LSP1) is a 52-kDa intracellular Ca2+- and F-actin-binding 
cytoskeletal and cytoplasmic protein [41-43] . LSP1 is phosphorylated as a result of chemokine 
stimulation, suggesting a role of LSP1 in myeloid cell activation and inflammation [44]. LSP1 was 
originally named lymphocyte specific protein-1 because of its initial identification in mouse and 
human B and T lymphocytes. It was subsequently renamed leukocyte-specific protein 1 to reflect its 
expression in macrophages/monocytes and neutrophils [45]. Furthermore, this protein was also 
discovered in dendritic cells and Langerhans’ cells [44]. It has been reported that ECs also express 
LSP1 [46]. Mouse and human LSP1 have 67% identical sequences, which are highly conserved 
phosphoproteins of 330 and 339 amino acids, respectively [39, 47, 48]. It has also been shown that 
the basic region of LSP1 contains serine and threonine residues and that LSP1 is phosphorylated in 
vivo [49]. Murine LSP1 (Fig.1.5) has a highly acidic N-terminal domain with Ca2+-binding regions, 
 
 
indicating its functions may be regulated by signal transduction [45]. LSP1 also has a basic amino 
acids C-terminal domain which is highly conserved and has high affinity regions for F-actin binding, 
indicating its importance for actin polymerization and cytoskeletal remodeling [45]. This C-terminal 
half of LSP1 also has several serine and threonine residues which are identified as potential 
phosphorylation sites by serine–threonine kinases such as MAPK-activated protein kinase-2 
(MAPKAPK2, also abbreviated as MK2) and protein kinase C (PKC) [46]. 
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Fig. 1.5 The schematic presentation of mouse LSP1 protein [45]. The putative Ca2+ binding 
sites at the N-terminal region (1–178), the PKC, MK2 phosphorylation sites, and the 
F-actin–binding region within the C-terminal domain (178–330) are indicated. (Modified from 
 
 
Reference 45) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
LSP1 is present at the cytoplasmic face of the plasma membrane in neutrophils and B 
lymphocytes [50, 51], whereas in ECs the majority of LSP1 is located in the nucleus with lower 
levels of LSP1 co-localizing with F-actin–rich microfilaments [46]. LSP1 rearranges polymerized 
F-actin to achieve cytoskeletal remodeling and cell motility during neutrophil chemotaxis [51]. 
Mouse LSP1 directly binds to F-actin via two high affinity F-actin binding regions [52], whereas 
human LSP1 contains four F-actin binding sites within its C-terminal domain [43]. 
LSP1 has been shown to be a major substrate of MK2 in the p38 MAPK signaling pathway 
[48]. MK2 and p38 MAPK have been reported to be necessary for neutrophil motility and 
chemotaxis [39, 53, 54], indicating that LSP1 may be important in transmigration and 
chemotaxis. In addition, LSP1 has also been shown to be a substrate for PKC [55, 56], which is 
another molecule involved in numerous neutrophil functions including adhesion, endothelial 
retraction and chemotaxis, suggesting that LSP1 may have multiple roles in neutrophil 
recruitment [46]. Furthermore, via this pathway, LSP1 has been shown to target proteins of the 
extracellular signal-regulated protein kinase (ERK)/MAPK pathway to specific sites and areas, 
indicating its complex functions in inflammation [57]. 
In summary, LSP1 is very important in neutrophil recruitment and chemotaxis because its 
main functions are directly related to intracellular signaling transduction, F-actin binding, 
cytoskeleton reorganization and cell motility. 
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1.4. Neutrophil Recruitment and LSP1 
 
 
 
1.4.1. LSP1 negatively regulates neutrophil recruitment 
 
 
 
Negative regulation of neutrophil migration by LSP1 has been shown in a variety of studies. 
One experimental model of inflammation induced in LSP1-deficient mice (Lsp1−/− mice) is the 
inflammation in the mouse knee joints by the injection of zymosan. The study showed that the 
number of resident synoviocytes in this inflammatory model was not affected by LSP1-
deficiency [58]. The authors also observed that in Lsp1−/− mice, the number of 
neutrophils migrating into the mouse knee joint was increased in zymosan-induced acute 
inflammation [58]. By using time-lapse video analysis in vitro, they also found that the 
migration speed toward a gradient of fMLP in chemotaxis experiments was also increased in 
Lsp1−/− mice when compared with that in WT neutrophils [58], and the difference was observed 
when cells migrated on fibrinogen (the receptor for β2 integrin), but not on fibronectin (the 
 
 
receptor for β1 integrin). Furthermore, it has been shown that LSP1 negatively regulates the 
fMLP-induced adhesion to fibrinogen or ICAM-1, but not to ICAM-2, VCAM-1, or fibronectin, 
indicating that LSP1 is a functional modulator of Mac-1 during neutrophil adhesion [58]. In 
addition, fMLP-induced F-actin polarization was also increased in the absence of LSP1 when 
cells were layered on fibrinogen, but not on fibronectin [58]. These results suggest that LSP1 is 
a negative regulator of neutrophil adhesion, polarization, and migration via Mac-1 during acute 
 
 
inflammation. 
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Another experimental model of inflammation is the induced mouse peritonitis model 
mediated by the injection of thioglycollate. Thioglycollate-induced neutrophils was isolated and 
the neutrophil chemotaxis in Lsp1−/− mice was two to three times increased when compared 
with that of those WT control neutrophils in response to fMLP in vitro[59]. Furthermore, 
 
 
increased phorbol 12-myristate 13-acctate (PMA)-induced superoxide production was detected 
in thioglycollate-elicited Lsp1−/− neutrophils as compared to WT neutrophils [51]. The negative 
regulatory role of LSP1 was also supported by the fact that neutrophils isolated from a patient 
with neutrophil actin dysfunction syndrome (NAD47/89) exhibited increased levels of LSP1 
and defects in migration, phagocytosis and spreading [60-62]. In addition, the over-expression 
of LSP1 in normally LSP1 negative, motile melanoma or U937 cells also demonstrated reduced 
motility [60, 63]. In conclusion, the research results from these studies suggest that high levels 
of LSP1 in the cytoplasm negatively regulated neutrophil motility and transmigration to 
inflamed sites via specific integrins such as Mac-1. 
 
1.4.2. LSP1 positively regulates neutrophil recruitment 
 
 
 
In a recent study using Lsp1−/− mice and control WT mice and their chimeric mice, it has 
been shown that endothelial LSP1 plays a positive role in the regulation of neutrophil 
transmigration in vivo [46]. By directly visualizing neutrophil rolling, adhesion, and emigration 
in post-capillary venules of cremaster muscle in Lsp1−/− mice using intravital microscopy, the 
authors found that LSP1 deficiency inhibited neutrophil recruitment in response to the 
 
 
chemokine KC as well as various cytokines ( e.g. TNFα, IL-1β) [46]. By using LSP1 chimeric 
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 mice which were generated via bone marrow transplantation, the authors found that in Lsp1−/− 
mice and WT→ Lsp1−/− mice, the number of neutrophils undergoing transendothelial migration 
was significantly decreased, although there was no effect on neutrophil rolling and adhesion in 
response to KC. In contrast, neutrophils of Lsp1−/− →WT mice and WT mice were able to 
transmigrate normally. Consistent with altered endothelial function, a reduced vascular 
permeability was observed in response to histamine in Lsp1−/− mice [46]. In addition, by using 
western blotting and immunofluorescence microscopy, LSP1 was confirmed to be present in 
WT mouse ECs and in human umbilical vein ECs but not in Lsp1−/− cells [46]. These studies 
demonstrated that LSP1 positively regulates neutrophil recruitment in vitro and that LSP1 in 
ECs is critical for neutrophil TEM. In addition, it has been reported that LSP1-deficient 
neutrophils show abnormal morphology and impaired migration speed in response to KC when 
compared to WT mice in vitro [51]. 
 
1.4.3. LSP1 is involved in cytoskeletal reorganizations and signal transduction 
 
 
 
It is well known that rearrangement of actin filaments has an important role in cytoskeletal 
reorganizations and cell motility and that LSP1 plays a role in cytoskeletal remodeling. 
Normally, neutrophils which express LSP1 do not have hair-like projections unless the LSP1 
protein level is abnormally high (example, 4-5 fold above basal) [64]. The over-expression of a 
47kDa protein (identified as LSP1), and reduced expression of a 89kDa protein, are named as 
 
 
neutrophil actin dysfunction (NAD) 47/89. Studies showed that over-expression of LSP1 in 
 
 
neutrophils of NAD patients lead to recurrent bacterial infections [60-62]. NAD neutrophils fail 
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to increase actin polymerization in response to chemotactic factors, display numerous thin, 
hair-like, F-actin-rich filamentous projections on their plasma membrane surfaces and have 
defects in chemotaxis, phagocytosis and spreading on glass [62]. In ECs, although cytoplasmic 
LSP1 expression was low, LSP1 had an agonistic effect in neutrophil emigration by interacting 
with actin filaments [46]. 
 
LSP1 has been shown to be a major substrate of the MK2 in the p38 MAPK pathway [48]. 
MK2 and p38 MAPK were reported to be essential for neutrophil motility and chemotaxis in 
response to fMLP [53]. Inhibition of p38 MAPK by SB203580 and PI3K inhibitor wortmanin 
inhibited the phosphorylation of p38 MAPK, MK2 and LSP1 in fMLP-treated human 
neutrophils, respectively, suggesting that PI3K was an upstream regulator of the p38 MAPK 
pathway in neutrophils [65]. Studies also showed that fMLP-induced LSP1 phosphorylation 
was important for its negative effects which were associated with neutrophil adhesion, 
polarization, crawling and chemotaxis [54, 66]. For the structural characteristics of LSP1, it can 
be phosphorylated by PKC and MK2 at distinct sites. It has been shown that PKC was not a 
regulator of the fMLP-induced p38 MAPK/MK2 pathway [56]. However, LSP1 directly 
interacted with PKCβI but not with PKCα or PKCβII. The PKCβI was involved in a larger 
signaling complex, ERK signaling pathway [45]. A hypothetical model for LSP1 function in the 
transmigration of neutrophils is illustrated in Fig. 1.6 below. 
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Fig. 1.6 A hypothetical model for LSP1 function in the transmigration of neutrophils. In 
neutrophils with high levels of LSP1 on the cytoskeleton, neutrophil recruitment is negatively 
regulated by LSP1 through MK2 signaling pathways in response to inflammatory stimuli such as 
fMLP or IL-1β. Once activated, the cascade of MK2 signaling pathways, LSP1 is phosphorylated 
and subsequently induces cytoskeletal remodeling via the integrin Mac-1 [58]. On the other hand, 
in the case of ECs where LSP1 levels in the cytoskeleton are low, phosphorylated LSP1 induces 
cytoskeletal remodeling and results in positive modulation of neutrophil transmigration through 
PKC or MK2 signaling pathways in response to KC [46]. 
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 2. Rationale for the study 
 
 
 
As mentioned above, neutrophil recruitment is a complex and sequential process and each 
step during neutrophil recruitment will be affected by the previous one. Although LSP1 is 
involved in positive regulation of transmigration in CXC chemokine KC-induced neutrophil 
emigration and chemotaxis both in vivo and in vitro [46, 51], the exact role of LSP1 in each step 
of neutrophil recruitment is still as yet incompletely understood. It has been reported that another 
CXC chemokine MIP-2 can induce chemotaxis through a PI3K-dependent mechanism and the 
PI3K signaling pathway is important in actin polarization, cell motility and migration [67]. 
However, whether and how LSP1 is involved in MIP-2-induced neutrophil recruitment is 
currently unknown. LSP1 is expressed both in neutrophils and in ECs [45] and endothelial LSP1 
is important for neutrophil emigration in response to KC [46]. However, the functional 
differences of neutrophil LSP1 and endothelial LSP1 in neutrophil recruitment are incompletely 
understood. In addition, it has been established that p38 MAPK signaling pathway is involved in 
KC-elicited neutrophil recruitment [39], whether it is involved in MIP-2-induced neutrophil 
recruitment is unclear. Furthermore, if p38 MAPK-activation is involved in MIP-2-induced 
neutrophil recruitment, whether the effects are achieved through LSP1 or not is another question. 
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 3. Working Hypothesis 
 
 
 
Based on the above, the following working hypotheses are formulated: 
 
 
a. LSP1 regulates MIP-2-and KC-induced neutrophil recruitment and chemotaxis through 
different mechanisms. 
 
b. LSP1 expressed in endothelium is crucial in regulating neutrophil recruitment and 
chemotaxis in tissue in response to the neutrophil chemokines, MIP-2 and KC. 
 
c. MIP-2-induced neutrophil recruitment is dependent on the p38 MAPK signaling 
pathway. 
 
 
 
 
 
 
4. Experimental Objectives 
 
 
 
a. To determine the role of LSP1 in neutrophil recruitment in the response to MIP-2 and KC 
 
 
in vivo. 
 
 
 
b. To identify the role of neutrophil and endothelial LSP1 in neutrophil chemotaxis assay in 
vivo. 
c. To determine if the p38 MAPK pathway is involved in MIP-2-induced neutrophil 
recruitment. 
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 5. Materials & Methods 
 
 
 
5.1. Animals 
 
 
 
Control, wild-type (WT) 129/SvJ mice were originally from The Jackson Laboratory (Bar 
Harbor, ME). Jongstra-Bilen and colleagues generated the Lsp1−/− mice on the 129/SvJ 
background by homologous recombination as described previously [59]. Both strains of mice 
were obtained from the lab of Dr. Paul Kubes at the University of Calgary and transferred to the 
University of Saskatchewan. The mice were bred at the University of Saskatchewan Animal 
Resource Centre and used in experiments when they were between 6 and 12 weeks of age. 
Four types of bone marrow (BM) chimeric mice were generated following the standard 
protocols from Dr. Paul Kube’s laboratory [68]. The BM cell suspensions from 6-8-wk-old donor 
Lsp1−/− and 129/SvJ WT mice were injected into the tail vein of Lsp1−/− and 129/SvJ WT mice 
respectively to generate Lsp1−/−→ Lsp1−/−, Lsp1−/−→WT, WT→ Lsp1−/−, WT→WT mice. After 
 
 
bone marrow transplantation (BMT), these mice were housed in specific pathogen-free facilities 
for 6–10 wk to allow full humoral reconstitution before use in experiments. All animal protocols 
and procedures were approved by the University Committee on Animal Care and Supply at the 
University of Saskatchewan and conformed to Canadian Council for Animal Care Guidelines. 
 
 
 
5.2. Bone Marrow Transplantation (BMT) 
 
 
 
The 6-8-wk-old recipient mice were taken to the γ source (Gammacell, 137Cs γ-irradiation 
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source). To get the 500-525 rad/min radiation, the exact time was calculated according to the 
current activity of the γ source. Recipient mice were irradiated for the specified length of time and 
put back in cages with food and water. A second irradiation was performed after a 3-hour interval. 
Bone marrow cells were isolated using an aseptic technique and cell samples were prepared in 
insulin syringes. The irradiated recipient mice were placed into a prepared injection tube (50 ml 
Falcon, with hole in lid and air holes down sides, sterilized in ethanol) and Kimwipes was put into 
it to minimize the mouse movement. The tail was brought out through the hole in the lid and 
sterilized with 70% ethanol. The tail was warmed up with warm water and i.v. injected with at 
least 8 × 106  cells in 0.2 ml physiological saline with a 27G needle. The anti-bacterial solution 
 
 
enrofloxacin, 1ml in 250ml of distilled water (Bayer Inc., Animal Health, Toronto, Ontario, 
Canada) was prepared daily as drinking water for the number of cages for the first two weeks 
after BMT. 
 
 
 
5.3. Mouse Preparation for Intravital Microscopy 
 
 
 
A mixture of 10 mg/kg xylazine (Bayer Inc., Animal Health, Toronto, Ontario, Canada) and 
200 mg/kg ketamine hydrochloride (Bioniche, Animal Health, Belleville, Ontario, Canada) were 
injected i.p. to anesthetize the adult male mice. The area over the right-side external jugular vein 
and the anterior aspect of the scrotum were shaved with an electric razor. An incision was made 
on the neck to expose the jugular vein, which was catheterized with a PE-10 tubing (Becton 
Dickinson, Canada) filled with 100 U/ml heparin saline (Sigma, Canada). For all protocols, the 
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right-side jugular vein was cannulated to administer additional anesthetic or drugs when 
necessary. 
 
 
 
5.4. Intravital Microscopy of Cremaster Muscle 
 
 
 
The mouse cremaster muscle preparation was used to study the behavior of neutrophil 
recruitment in the microcirculation and adjacent connective tissue. Briefly, the preparation 
involved an incision in the scrotal skin to expose the left cremaster muscle, which was then 
carefully dissected to free it from the associated fascia. The cremaster muscle was then cauterized 
longitudinally. The testicle and the epididymis were disassociated from the underlying muscle and 
moved into the abdominal cavity. The muscle was secured along the edges with 5–0 suture and 
bicarbonate-buffered physiological saline (131.9 NaCl, 4.7 KCl, 1.2 MgSO4, 20 NaHCO3, in mM, 
pH 7.4, 37°C) superfused over the exposed tissue. The muscle was held flat and covered with a 22 
× 22 mm glass coverslip on an optically clear viewing pedestal of a home-made cremaster muscle 
board. The cremasteric microvasculature was visualized using an intravital microscope (Carl 
Zeiss, Germany) with a 16× objective lens and a 10x eyepiece. A CCD video camera (DC220, 
Dage-MIT, USA) was used to project the images onto a monitor. The images were recorded with 
a high definition HD-DVD recorder for subsequent playback real-time analysis to determine 
neutrophil rolling, adhesion and transmigration and time-lapse analysis to observe and measure 
neutrophil intraluminal crawling, transendothelium migration and chemotaxis in tissue. 
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5.5. Induction of Neutrophil Recruitment in Cremaster Muscle 
 
 
 
To induce neutrophil recruitment independent of cytokines, an agarose gel containing MIP-2 
(R&D Systems, Inc., Minneapolis, USA) or KC (Peprotech, Rocky Hill, USA) was used. The 2% 
agarose gel in PBS was prepared by adding 10 ml of 2 × PBS to a boiling concentrated agarose 
solution (4% in 10 ml of distilled water). A 110-µl aliquot of this solution was added into the lid 
of a 1.5-ml Eppendorf tube containing MIP-2 or KC and mixed to achieve a final concentration of 
 
 
0.5 µM. A small amount of India ink was added to the lid in order to visualize the gel on the 
cremaster muscle. For the dose-response studies, MIP-2 or KC at 0.05, 0.5, 1.5 µM prepared in 
agarose gel was used to induce neutrophil recruitment in mice. After 30 min recording of the 
image of the selected post-capillary venule, the superfusion was stopped and the coverslip was 
removed from the muscle. A 1 mm3  piece of MIP-2 or KC-containing gel was punched out of the 
lid using the cut tip end of a 200-μl pipette and the gel is carefully placed on the surface of the 
cremaster muscle in a preselected area 350 µm from the observed post-capillary venule. A 22 × 
22 mm glass coverslip was added to the muscle to hold the gel in place and the tissue was 
 
 
superfused beneath the coverslip at a very slow rate (≤10 µl/min) to allow the establishment of a 
gradient of chemoattractant that is slowly released from the gel. The images were recorded for 90 
min after the addition of chemoattractant containing gel. 
 
 
 
5.6. Inhibition of p38 MAPK 
 
 
 
The animals were treated with one of the two different p38 MAPK inhibitors: SB203580 or 
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SKF860002. SB203580 (EMD Chemicals, Gibbstown, USA) was given i.v. 30 min before 
administration of MIP-2 in a dose of 20 mg/kg based on previously reported optimal concentrations 
[69]. SKF86002 (EMD Chemicals, Gibbstown, USA) was given locally by superfusion at a dose of 
0.7 mM based on previously reported optimal concentrations [70] 30 min before or after 
administration of MIP-2, respectively. 
 
 
 
5.7. Evaluation of the Neutrophil Recruitment Parameters 
 
 
 
The number of rolling, adherent, and emigrated neutrophils was determined offline during 
real-time video playback analysis as described [46]. The transmigration time, detach time, and 
data of intraluminal crawling and chemotaxis in tissue were obtained from time-lapse movie 
playback analysis. 
 
 
 
5.7.1. Analysis of rolling velocity, rolling flux, adhesion and emigration cell 
 
 
 
Neutrophil rolling velocity was measured from the first 20 neutrophils which entered the field 
of view at the recording time. It was calculated from the time which was required for an average 
neutrophil to roll along a 100-μm length of venule and expressed as μm/sec. The rolling flux was 
measured as the number of rolling neutrophils passing by a given point in the observed venule per 
min (averaged from 3 min). Neutrophil was defined as adherent if it remained stationary for at 
least 30 sec, and the total neutrophil adhesion was measured as the number of adherent cells 
 
 
within a 100-μm length of venule in 5 min. Neutrophil emigration was defined as the number of 
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 emigrated neutrophils in the extravascular tissue within a 200 × 300-μm area (0.06 mm2) adjacent 
to the observed venule. 
 
 
 
5.7.2. Tracking cell movement both in vessel and tissue with time-lapse movies 
 
 
 
5.7.2.1. Analysis of time-lapse video using ImageJ 
The recorded video was imported into a computer and transformed to a time-lapse movie in 
AVI format with computer software bitRipper and Windows Movie Maker. The neutrophil 
movement was manually tracked in the lumen, during transendothelial migration, and in muscle 
tissue one by one and frame by frame with software ImageJ (downloaded from 
http://rsb.info.nih.gov/ij/download.html). The cell tracking results were saved in Microsoft Excel 
 
automatically. 
 
 
5.7.2.2. Intraluminal crawling 
 
 
a. Crawling distance: the total distance the cell crawls from the initial adherent site to the 
transmigration site (µm). 
b. Crawling chemotaxis distance: the distance the cell crawls in x-axis in the lumen (µm) 
 
 
c. Intraluminal crawling time: the total time the cell crawls from the initial adherent site to 
the transmigration site (min) 
d. Crawling velocity: crawling distance divided by intraluminal crawling time (µm/min) 
e. Crawling chemotaxis index: the ratio achieved by dividing the chemotaxis distance by the 
crawling distance in the lumen. 
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5.7.2.3. Transendothelial migration 
 
 
a. Transmigration time: from the time the cell starts to transmigrate across endothelium to 
the time the cell body is just outside the venule (min). 
b. Detachment time: from the time the cell body is just outside the venule (immediately after 
transmigration) to the time point when the cell loses contact with the venule (the tail retracts) (min). 
5.7.2.4. Chemotaxis in tissue 
 
 
a. Migration distance: the sum of the migration distance the cell moves from the start point 
to the end point of the migration in tissue (µm) 
b. Chemotaxis distance: the distance the cell migrates in x-axis in tissue (µm) 
 
 
c. Chemotaxis velocity: the chemotaxis distance/time (µm/min) 
 
 
d. Chemotaxis index: the ratio achieved by dividing the chemotaxis distance by the 
migration distance in tissue. 
 
 
 
5.8. Genotyping 
 
 
 
The genomic DNA from samples of mouse blood and tail clips was extracted by using Wizard 
Genomic DNA Purification Kit (Promega, Madison, USA) following the manufacture’s procedures. 
Using GoTaq Flexl DNA polymerase (Promega, Madison, USA), we analyzed the genotypes of 
LSP1 chimeric mice according to the manufacture’s procedures. Primer sequences of WT, Lsp1−/− 
and hybrids used were (P123 and P124 for Lsp1−/−genotype, 159bp; P123 and P125 for WT 
 
 
genotype, 333bp): 
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P123: AGA AAC ACC AGG AGC CAT AAC AAG 
P124: AGA ACG AGA TCA GCA GCC TCT G 
P125: CAG TCC CTT CAC ACC AAG CAT C 
The PCR parameters were set as following: one cycle for 5 min at 95°C; 35 cycles of 95°C for 
 
 
30 sec, 56°C for 30 sec, 72°C for 30 sec; one cycle for 7 min at 72°C and hold samples at 4°C until 
loading. PCR samples were then run on 1% agarose gel for visualization (PCR product 333bp for 
WT; 159bp for Lsp1−/−; both 333bp and 159bp for hybrid). 
 
 
 
5.9. Statistical analysis 
 
 
 
The data are expressed as means ± SEM. One-way ANOVA followed by post hoc comparisons 
was applied to compare the statistical difference within two groups. A P-value of < 0.05 or 0.01 was 
considered statistically significant or very significant, respectively, and the number of each group 
was at least three mice. 
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 6. Results 
 
 
 
6.1 The role of LSP1 in chemokine-induced neutrophil recruitment 
 
 
6.1.1. Dose-response curve of MIP-2- and KC-induced neutrophil recruitment 
 
 
To obtain an optimal dosage and time point, recruitment responses of neutrophils from 
 
 
129/SvJ mice to both MIP-2 and KC at 0.05 µM, 0.5 µM, or 1.5 µM doses or saline in agarose gel 
were assessed. The responses were recorded for 120 min: 30 min for the control treatment (no 
agarose gel) and 90 min for the MIP-2, KC or saline-containing gel. 
Fig. 6.1 shows that in response to MIP-2, the different doses induced similar responses in 
neutrophil rolling velocity and rolling flux, but significant increased neutrophil adhesion and 
emigration when compared to the saline-containing gel controls. The 0.5 µM dose was found to 
be the optimal one: the number of emigrating cells were substantially increased compared to a 
0.05 µM dose at 90 min; with increasing time, the adhesion in response to 0.5 µM remained in 
plateau after 30 min while the adhesion tendency of 1.5 µM was reduced after 30 min; and the 
number of emigrating cells at 0.5 µM was much greater than that at 1.5 µM at 60 min and 90 min. 
At 90 min, the number of adherent cells at the 0.5 µM dose showed a slight increase while 
emigrating cells exhibited a significant increase compared to 60 min. As a result, the optimal time 
point for neutrophil emigration was at 90 min for the MIP-2 treatment. 
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Fig. 6.1 The dose-response and kinetics of neutrophil recruitment induced by MIP-2 in 
agarose gel. (A)  The velocity of rolling neutrophils, (B) the flux of rolling neutrophils, (C) 
neutrophil adhesion, and (D) neutrophil emigration in cremaster post-capillary venules of 129/SvJ 
mice were determined by intravital microscopy at 30, 60 and 90 min after the addition of 0.05 
(open squares), 0.5 (solid circles) or 1.5 (open circles) µM  MIP-2 or saline (solid squares) in 
agarose gel (n = 3 in each group). *P < .05 and **P < .01 as compared with each value in control 
mice. #P < .05 means 0.5 µM  MIP-2-in-gel compared with 0.05 µM MIP-2-in-gel. Error bars 
represent means ± SEM. 
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The dose response curve of KC was similar to that of MIP-2 although MIP-2 was more potent 
in inducing neutrophil recruitment than was KC (Fig. 6.1 & Fig. 6.2). In conclusion, neutrophil 
recruitment is similar in response to MIP-2- or KC-in-gel treatment and 0.5 µM MIP-2 or KC for 
90 min elicits the highest number of emigrated neutrophils 
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Fig. 6.2 The  dose-response  and  kinetics  of  neutrophil  recruitment  induced  by  KC  in 
agarose gel.  (A)  The velocity of rolling neutrophils, (B) the flux of rolling neutrophils, (C) 
neutrophil adhesion, and (D) neutrophil emigration in cremaster post-capillary venules of 129/SvJ 
mice were determined by intravital microscopy at 30, 60 and 90 min after the addition of 0.05 
(open squares), 0.5 (solid circles) or 1.5 (open circles) µM KC or saline (solid squares) in an 
agarose gel (n = 3 in each group). *P < .05 and **P < .01 as compared with each value in control 
mice. #P < .05 means 0.5 µM KC-in-gel compared with 0.05 µM KC-in-gel. Error bars represent 
means ± SEM. 
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6.1.2. The role of LSP1 in MIP-2 and KC-induced neutrophil recruitment 
 
 
To determine the role of LSP1 in neutrophil recruitment in response to MIP-2 or KC, I used 
intravital microscopy to observe neutrophil rolling velocity, rolling flux, adhesion and emigration. 
The data for MIP-2- and KC-induced neutrophil recruitment in Lsp1−/− mice were compared with 
the data from WT mice. 
In response to MIP-2, Lsp1−/− mice exhibited similar responses in neutrophil rolling flux and 
velocity, but a decrease of neutrophil adhesion and more significant decrease of emigration in 
neutrophil recruitment compared to WT mice (Fig. 6.3). At 90 min, the number of adherent cells 
in Lsp1−/− mice decreased to about eight cells, about half the number of that in WT mice. The 
number of emigrating cells in Lsp1−/− mice was significantly lower as early as 30 min and about 
half of that in WT mice at 60 min, and only thirty percent at 90 min. As a result, the role of LSP1 
in MIP-2-induced neutrophil recruitment is effective mainly in the step of emigration and slightly 
effective during neutrophil adhesion but only at 90 min. 
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Fig. 6.3 The role of LSP1 in MIP-2-containing gel-induced neutrophil recruitment. (A) 
The velocity of rolling neutrophils, (B) the flux of rolling neutrophils, (C) neutrophil adhesion, 
and (D) neutrophil emigration in cremaster post-capillary venules of Lsp1−/−  (open squares) and 
WT (solid squares) mice are shown (n = 5 in each group). After measurement of basal neutrophil 
recruitment  (at  time  0),  neutrophil  recruitment  was  induced  by   the  addition  of  0.5  µM 
MIP-2-in-gel. *P < .05 and **P < .01 as compared with each value in WT control mice. Error 
bars represent means ± SEM. 
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 Neutrophil recruitment induced by chemokine KC was similar to that induced by MIP-2 
and the crucial steps where LSP1 played a role was the neutrophil emigration (Fig. 6.4). 
Consequently, for further study, the data of neutrophil recruitment in the MIP-2 containing gel 
treated mice were shown in the following text. 
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Fig. 6.4 The role of LSP1 in KC-containing gel-induced neutrophil recruitment. (A) The 
velocity of  rolling neutrophils, (B) the flux of rolling neutrophils, (C) neutrophil adhesion, and 
(D) neutrophil emigration in cremaster post-capillary venules of Lsp1−/−  (open squares) and WT 
(solid squares) mice are shown (n = 5 in  each  group). After measurement of basal neutrophil 
recruitment (at time 0), neutrophil recruitment was induced by the addition of 0.5 µM KC-in-gel. 
*P < .05 and **P < .01 as compared with each value in WT control mice. Error bars represent 
 
 
means ± SEM. 
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To determine the exact functions of LSP1 in each step of neutrophil recruitment, we 
combined intravital microscopy with time-lapse video photography to analyze neutrophil 
recruitment in much more details (Fig. 6.5). During intraluminal crawling, neutrophils in Lsp1−/− 
mice exhibited defects both in the crawling distance and the crawling chemotaxis in x-axis. The 
velocity of crawling distance, velocity of crawling chemotaxis (Fig. 6.5A), intraluminal crawling 
chemotaxis index (Fig. 6.5C) were all significantly decreased and the crawling time (Fig. 6.5B) 
was significantly increased in Lsp1−/− mice compared to these parameters in WT mice. After 
crawling to the optimal sites, neutrophils underwent transendothelial migration and detached from 
the cremaster post-capillary venules. Neutrophils in Lsp1−/− mice substantially displayed longer 
transendothelial migration times but showed no defect on their detachment times (Fig. 6.5B). 
During chemotaxis in extravascular tissue, neutrophils in Lsp1−/− mice exhibited lower velocity of 
migration, lower velocity of chemotaxis and a depressed chemotaxis index (Fig. 6.5C&D). The 
 
 
velocity defected in x-axis movement was much more obvious than that of total movement of 
neutrophils in Lsp1−/−  mice, when compared to these parameters in WT mice both in the lumen 
and in tissue (Fig. 6.5A&D), suggesting an important role of LSP1 in chemotaxis. In addition, the 
chemotaxis index data showed that neutrophils in Lsp1−/− mice migrated more randomly while 
neutrophils in WT mice migrated in a more directed fashion toward the chemokine both in the 
lumen and in tissue (Fig. 6.5C). Thus, LSP1 is essential for neutrophil-endothelial cell 
interactions, especially for intraluminal crawling and transendothelial migration, and regulates the 
subsequently directional migration in tissue in response to MIP-2. 
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Fig.  6.5 The  role  of  LSP1  in  MIP-2-containing  gel-induced  neutrophil  intraluminal 
crawling, transendothelial migration, and chemotaxis in tissue. (A) The velocity of crawling 
distance and crawling  chemotaxis, (B) the intraluminal crawling time, transmigration time and 
detachment time, (C) crawling chemotaxis index and chemotaxis index in tissue, and (D) velocity 
of migration and chemotaxis in extravascular tissue of Lsp1−/−  (open bars) and WT (hatched bars) 
mice are shown (n = 6 or 7, total > 40 cells in each group). Neutrophil recruitment was induced by 
the addition of 0.5 µM MIP-2-in-gel. *P < .05 and **P < .01 as compared with each value in WT 
control mice. Error bars represent means ± SEM. 
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 6.2 The role of neutrophil LSP1 (N-LSP1) and endothelial LSP1 (E-LSP1) in 
 
 
MIP-2-induced neutrophil recruitment in chimeric mice 
 
 
Although the role of LSP1 in MIP-2-induced neutrophil recruitment has been investigated, 
the respective role of neutrophil LSP1 versus endothelial LSP1 is still unknown. Therefore, four 
types of chimeric mice (Lsp1−/−→Lsp1−/−, Lsp1−/−→WT, WT→Lsp1−/−, WT→WT) were 
generated and the same intravital microscopy experiments were performed to identify the cellular 
site of functional LSP1. By using PCR and the primers listed in Materials & Methods, we verified 
the genotypes of these generated chimeric mice. We confirmed, by analyzing the genotypes of 
blood samples and tail clips from chimeric mice, that the genotypes of the four types of chimeric 
mice were indeed as we anticipated, and these mice were used in the subsequent experiments. 
In response to MIP-2, the four types of chimeric mice exhibited similar responses in terms of 
neutrophil rolling velocity and rolling flux (Fig. 6.6). Although there was a decrease of adhesion 
in Lsp1−/−→Lsp1−/−mice compared to WT→WT mice at 90 min, no significant differences were 
observed between other groups (Lsp1−/−→Lsp1−/− vs Lsp1−/−→WT; Lsp1−/−→Lsp1−/− vs 
 
 
WT→Lsp1−/−; WT→WT vs Lsp1−/−→WT; WT→WT vs WT→Lsp1−/−), indicating that only when 
both N-LSP1 and E-LSP1 are deficient and at 90 min after MIP-2 treatment does LSP1 show a 
minor role in MIP-2-induced neutrophil adhesion (compare Fig. 6.6C to Fig. 6.3C). However, 
neutrophil emigration was inhibited in WT→Lsp1−/−  mice as well as in Lsp1−/−→Lsp1−/− mice but 
not in Lsp1−/−→WT mice or WT→WT mice (Fig. 6.6D). This indicates that, similarly to 
 
 
KC-induced neutrophil recruitment [46], MIP-2-induced neutrophil emigration is also endothelial 
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LSP1-dependent. In addition, the responses of neutrophil recruitment in WT→WT and 
Lsp1−/−→Lsp1−/− chimeric mice were identical to those of WT and Lsp1−/− mice (compare Fig. 6.3 
to Fig. 6.6), and the results of genotyping (data not shown) confirmed that our bone marrow 
transplantations had successfully taken place and were functional. 
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Fig. 6.6 The role of neutrophil LSP1 (N-LSP1) and endothelial LSP1 (E-LSP1) in 
 
 
MIP-2-gel-induced neutrophil recruitment. (A) The velocity of rolling neutrophils, (B) the flux 
of rolling neutrophils, (C) neutrophil adhesion, and (D) neutrophil emigration in cremaster 
post-capillary venules of four types of chimeric mice are shown (n = 4 in each group). 
 
 
Lsp1−/−→Lsp1−/− (solid circles): both the BM donor and recipient are Lsp1−/− mice; WT→Lsp1−/− 
 
 
(solid squares): the BM donor is 129/SvJ mice and recipient is Lsp1−/− mice; Lsp1−/−→WT (open 
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 squares): the BM donor is Lsp1−/− mice and recipient is 129/SvJ mice; WT→WT (open circles): 
both the BM donor and recipient are 129/SvJ mice. Neutrophil recruitment was induced by the 
addition of 0.5 µM MIP-2-in-gel. *P < .05 and **P < .01 as compared with each value in 
Lsp1−/−→Lsp1−/− mice. #P < .05 and ##P < .01 as compared with each value in WT→WT mice. 
Error bars represent means ± SEM. 
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For further study, I observed each step of neutrophil recruitment in these LSP1 chimeric mice 
by using time-lapse video photography. During intraluminal crawling (Fig. 6.7), the velocity of 
intraluminal crawling distance in Lsp1−/−→Lsp1−/− mice significantly decreased compared to the 
other three types of chimeric mice (Fig. 6.7.A), suggesting only when both N-LSP1 and E-LSP1 
are absent has LSP1 an impact on the velocity of intraluminal crawling. However, we found that 
the velocity of chemotaxis was dependent on E-LSP1 (Fig. 6.7.B). Additionally, the intraluminal 
crawling chemotaxis index was completely E-LSP1-dependent (Fig. 6.7.C). On the other hand, 
either N-LSP1 deficiency or E-LSP1 deficiency led to increased crawling times (Fig. 6.7.D). As a 
result, both N-LSP1 and E-LSP1 are involved in neutrophil intraluminal crawling, while E-LSP1 
plays a more important role in neutrophil directional crawling towards the chemoattractant. 
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Fig. 6.7 The role of neutrophil LSP1 (N-LSP1) and endothelial LSP1 (E-LSP1) in MIP-2-
induced neutrophil intraluminal crawling in cremaster post-capillary venules of chimeric 
mice. (A) The velocity of intraluminal crawling distance, (B) the velocity of intraluminal crawling 
chemotaxis, (C) intraluminal crawling chemotaxis index, and (D) intraluminal crawling time of four 
types of chimeric mice are shown (n = 5 or 6, total > 40 cells in each group, KO means Lsp1−/−). 
Neutrophil recruitment was induced by the addition of 0.5 µM MIP-2-in-gel. *P < .05 and 
**P < .01 as compared with each value in Lsp1−/−→ Lsp1−/− mice. #P < .05 and ##P < .01 as 
 
 
compared with each value in WT→WT mice. Error bars represent means ± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
 
After crawling to the optimal sites, neutrophils undergo the transendothelial migration and 
after transmigration, then detach from the cremaster post-capillary venules. My transmigration 
data showed that both N-LSP1 and E-LSP1 had effects on neutrophil transmigration (Fig. 6.8). 
Either N-LSP1 or E-LSP1 must be present to have a normal transmigration time. Four types of 
chimeric mice exhibited no significant differences in detachment time (data not shown). 
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Fig.  6.8 The  role  of  neutrophil  LSP1  (N-LSP1)  and  endothelial  LSP1  (E-LSP1)  in 
MIP-2-induced   transendothelial   migration   from   cremaster   post-capillary   venules   of 
chimeric mice (n = 5 or 6, total  >  40 cells in each group, KO means Lsp1−/−). Neutrophil 
recruitment was induced by the addition of 0.5 µM  MIP-2-in-gel. *P < .05 and **P < .01 as 
compared with each value in Lsp1−/−→Lsp1−/− mice. Error bars represent means ± SEM. 
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Following transmigration, neutrophils migrate towards the source of chemoattractant within 
the tissue (Fig. 6.9). We found that the velocity of neutrophil migration in tissue was much more 
dependent on N-LSP1 (Fig. 6.9.A). However, the situation of the velocity of chemotaxis and 
chemotaxis index were different (Fig. 6.9.B&C). It is interesting to note that, there was a 
significant decrease in neutrophil chemotaxis index in tissue in Lsp1−/−→Lsp1−/− mice and 
WT→Lsp1−/− mice but not in Lsp1−/−→WT mice, indicating that N-LSP1 is not crucial in 
 
 
determining neutrophil chemotaxis index in response to MIP-2 in tissue. It also suggested that 
 
 
E-LSP1 may play a more important role in determining the subsequent neutrophil chemotaxis in 
tissue. Therefore, N-LSP1 has effects on the velocity of neutrophil migration in tissue whereas 
E-LSP1 may have a crucial role in neutrophil chemotaxis in issues in response to MIP-2. 
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Fig. 6.9 The role of neutrophil LSP1 (N-LSP1) and endothelial LSP1 (E-LSP1) in MIP-2 
induced neutrophil migration and chemotaxis in tissue after their transmigration across 
cremaster post-capillary venules of chimeric mice. (A) The velocity of migration in tissue, (B) 
the velocity of chemotaxis in tissue, and (C) chemotaxis index in tissue of four types of chimeric 
mice are shown (n = 5 or 6, total > 40 cells in each group, KO means Lsp1−/−). *P < .05 and **P 
< .01 as compared with each value in Lsp1−/−→Lsp1−/− mice. Neutrophil recruitment was induced 
 
 
by the addition of 0.5 µM MIP-2-in-gel. #P < .05 and ##P < .01 as compared with each value in 
 
 
WT→WT mice. Error bars represent means ± SEM. 
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These data showed that the E-LSP1 is critical for MIP-2-induced neutrophil emigration. Both 
N-LSP1 and E-LSP1 have effects on neutrophil intraluminal crawling, transendothelial migration 
and migration in tissue. However, the directional neutrophil movement towards MIP-2 is much 
more dependent on the functions of E-LSP1 during neutrophil-endothelial cell interactions in the 
lumen. In addition, neutrophil chemotaxis in tissue seems to be E-LSP1-dependent. 
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 6.3 Role of p38 MAPK in MIP-2-induced neutrophil recruitment 
 
 
It was reported that p38 MAPK is involved in KC-induced neutrophil recruitment [39]. To 
investigate the role for p38 MAPK in MIP-2-induced neutrophil recruitment, I performed the 
same neutrophil recruitment assay using MIP-2-in-gel, but with p38 MAPK inhibitor SB203580 
or SKF86002 treatments in 129/SvJ mice. Firstly, the 129/SvJ mice were treated by i.v. injection 
of SB203580 (20 mg/kg) 30 min before MIP-2-in-gel addition. My results revealed that this 
systematic treatment with SB203580 completely abolished neutrophil recruitment (data not 
shown). As a result, we conclude that, similar to the role of p38 MAPK in KC-induced neutrophil 
recruitment [39], MIP-2-induced neutrophil recruitment is indeed dependent on p38 MAPK 
pathway. 
Next, I performed a local inhibition study by superfusion of the cremaster muscle with 
 
 
SKF86002 (0.7 mM). The mice were treated with SKF86002 superfusion 30 min before 
 
 
MIP-2-in-gel administration. The results showed that compared with saline-treated control mice, 
the SKF86002 pretreated mice exhibited similar responses in rolling velocity and rolling flux, 
indicating that p38 MAPK may not play an important role in neutrophil rolling in the venule. The 
number of adherent cells was reduced to about 50% of control values, whereas emigration was 
completely abolished at all time points tested (Fig. 6.10). My data indicated that MIP-2-induced 
neutrophil emigration is definitely dependent on the functions of p38 MAPK, whereas neutrophil 
adhesion in the venules is only partly dependent on this kinase. 
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Fig. 6.10 The role of p38 MAPK in MIP-2-containing gel-induced neutrophil recruitment. 
(A)  The  velocity  of  rolling  neutrophils,  (B)  the  flux  of  rolling  neutrophils,  (C)  neutrophil 
adhesion,  and  (D)  neutrophil  emigration  in  cremaster  post-capillary  venules  of  SKF86002 
pretreated mice (open squares) and untreated WT (solid squares) mice are shown (n = 3 in each 
group). The cremaster muscle was treated with or without 30 min 0.7 mM SKF86002 superfusion 
before MIP-2-in-gel  administration,  and  the muscle remained  superfused  with  SKF86002  or 
saline after addition of MIP-2-in-gel. *P < .05 and **P < .01 as compared with  each value in 
control mice. Error bars represent means ± SEM. 
 
 
 
60 
 
To further investigate the role of p38 MAPK in neutrophil migration and chemotaxis in tissue, we 
superfused the cremaster muscle with SKF86002, after 30 min MIP-2-in-gel treatment when some 
neutrophils had transmigrated and  just begun to chemotaxis in tissue (Fig. 6.11). In response to 
MIP-2, SKF86002-treated mice exhibited a similar rolling velocity to that in control mice. The 
rolling flux and adherent cells were significantly decreased after 30 min of SKF86002 superfusion. 
Neutrophil emigration displayed substantial inhibition after superfusion for 60 min. These results 
suggest that p38 MAPK plays an important role in neutrophil rolling flux, adhesion and emigration 
in response to MIP-2. 
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Fig. 6.11 The role of p38 MAPK in MIP-2-containing gel-induced neutrophil recruitment. 
(A)  The  velocity  of  rolling  neutrophils,  (B)  the  flux  of  rolling  neutrophils,  (C)  neutrophil 
adhesion, and (D) neutrophil emigration in cremaster post-capillary venules of SKF86002 treated 
mice (open squares) and saline-treated WT (solid squares) mice are shown (n = 3 in each group). 
The  cremaster  muscle  was  treated  with  or  without  60  min  0.7  mM  SKF86002  superfusion 
(indicated as an arrow and solid line in the figures), after 30 min MIP-2-in-gel  administration 
when some neutrophils had transmigrated and just begun to chemotaxis in tissue. *P < .05 and 
**P < .01 as compared with each value in control mice. Error bars represent means ± SEM. 
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To determine the role of p38 MAPK in neutrophil migration and chemotaxis in tissue, I 
tracked the movement and measured the directionality of those transmigrated neutrophils after 
SKF86002 superfusion of cremaster muscle where the MIP-2-in-gel had been applied to induce 
neutrophil recruitment 30 min before SKF86002 superfusion (Fig. 6.12). The velocity of 
neutrophil migration, velocity of chemotaxis and chemotaxis index in tissue were all decreased in 
SKF86002-treated mice compared to SKF86002 untreated mice. As a result, neutrophil migration 
and chemotaxis in tissue are dependent on p38 MAPK-activation. 
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Fig. 6.12 The role of p38 MAPK in MIP-2-induced neutrophil migration and chemotaxis 
in tissue in 129/SvJ mice. (A) The velocity of migration in tissue, (B) the velocity of chemotaxis 
in tissue, and (C) chemotaxis  index in tissue in cremaster post-capillary venules of SKF86002 
treated  and  untreated  WT  mice  (n  =  3,  total>  20  cells  in  each  group).  After  30  min  of 
MIP-2-in-gel addition when some neutrophils had transmigrated across endothelium, SKF86002 
(0.7 mM) was superfused on the muscle and the experiment was continued for additional 60 min 
to record the cellular movement in tissue after transmigration. **P < .01 as compared with each 
value in control mice. Error bars represent means ± SEM. 
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In neutrophils, LSP1 is one of the downstream effector molecules in the p38 MAPK signaling 
pathway  [71],  and  the  results  from  Part  B  indicate  that  neutrophil  chemotaxis  in  tissue  is 
E-LSP1-dependent  but   N-LSP1-independent.  To  further  study  the  role  of  p38  MAPK  in 
neutrophil chemotaxis in tissue, I performed the same assay using Lsp1−/−→WT chimeric mice to 
determine  if  LSP1  is  involved  in  the  inhibitory  effect  of  p38  MAPK  inhibitor  (Fig.  6.13). 
Interestingly, the velocity of  migration, the velocity of chemotaxis and  chemotaxis index of 
N-LSP1-deficient neutrophils were all significantly decreased after the treatment with SKF86002 
when compared to the group without p38 MAPK inhibition (Fig. 6.13). These results suggest that: 
(1) in response to MIP-2-in-gel, Lsp1−/− neutrophils in WT mice had a defect in migration in tissue 
indicating  that  N-LSP1  plays  an  important  role  in  determining  the  velocity  of  neutrophil 
migration in tissue (Fig. 6.9A). In these mice,  SKF86002 further decreased Lsp1−/− neutrophil 
migration in tissue (Fig. 6.13A), suggesting that in addition to LSP1, neutrophils rely on another 
signaling pathway that is also downstream of p38 MAPK to mediate some migration response in 
tissue; (2) I  demonstrated in Fig. 6.9B&C that Lsp1−/− neutrophils in WT mice had a normal 
chemotaxis response in tissue,  suggesting that neutrophil chemotaxis in tissue in response to 
MIP-2 is E-LSP1-dependent and N-LSP1-independent. Here, my results in Part C (Fig. 6.13B&C) 
revealed that these Lsp1−/− neutrophils still rely on the functions of p38 MAPK for chemotaxis in 
tissue, suggesting the fundamental importance of p38 MAPK in neutrophil chemotaxis, and the 
 
 
existence of another signaling pathway downstream of p38 MAPK that is involved in neutrophil 
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chemotaxis in tissue. Overall, my results suggest that MIP-2-induced neutrophil chemotaxis in 
 
 
tissue is p38 MAPK dependent but N-LSP1 independent. 
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Fig. 6.13 The role of  p38  MAPK in  MIP-2-induced  Lsp1−/−   neutrophil  migration  and 
chemotaxis in tissue in Lsp1−/−→WT chimeric mice. (A) The velocity of migration in tissue, 
(B) the velocity of chemotaxis  in tissue, and (C) chemotaxis index in tissue of the cremaster 
post-capillary venules of SKF86002 treated and  untreated Lsp1−/−→WT chimeric mice (n = 3, 
total> 20 cells in each group). Neutrophil recruitment was induced in and p38 MAPK inhibitor 
SKF86002 was applied to the cremaster muscle of Lsp1−/−→WT chimeric mice as described in 
the legend of  Fig  6.12. **P < .01 as compared with each value in control mice. Error bars 
represent means ± SEM. 
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 7. Discussion 
 
 
 
7.1. LSP1 positively regulates neutrophil recruitment in response to MIP-2 
 
 
 
The Ca2+ and F-actin binding intracellular phosphoprotein LSP1 has been shown to play an 
important role in neutrophil recruitment through its mediation of signal transduction and its 
involvement in cytoskeleton rearrangement. Neutrophil recruitment is a very dynamic process and 
a hallmark feature of inflammatory response. Many stimuli, such as fMLP, IL-8 and KC have 
been shown to initiate multiple intracellular effects that induce neutrophil recruitment. Both in 
vivo and in vitro studies have confirmed that LSP1 plays an important role in CXC chemokine 
KC-induced neutrophil emigration and chemotaxis [46, 51]. However, the mechanism of this 
positive regulation of LSP1 is still unclear. Furthermore, another CXC chemokine, MIP-2, induce 
neutrophil migration in a PI3K-dependent manner [67] and the PI3K pathway is known to be 
important in actin polarization, cell motility and migration. However, whether LSP1 is involved 
in MIP-2-induced neutrophil chemotaxis is currently unknown. In addition, the functional 
differences of neutrophil LSP1 (N-LSP1) and endothelial LSP1 (E-LSP1) in neutrophil 
intraluminal crawling, TEM and chemotaxis in tissue are incompletely understood. These create a 
need to extend our understanding of the role of E-LSP1 and N-LSP1 in chemokine MIP-2- and 
KC-induced neutrophil recruitment. 
It is well known that neutrophil directional migration can be induced by chemokines or other 
 
 
chemoattractants both in vivo and in vitro. Phillipson et al. recently showed that in the presence of 
 
 
shear flow in vivo, neutrophils exhibited intraluminal crawling in a perpendicular direction to the 
68 
 
vessel lumen by the regulation of Vav1, a major regulator of the organization of the actin 
cytoskeleton during neutrophil polarization and migration [72]. Menezes et al. demonstrated that 
a chemokine gradient was formed intravascularly and neutrophils crawled towards the 
chemoattractant [5]. My intraluminal crawling data demonstrated that neutrophils in WT mice 
crawled towards MIP-2 and suggested the existence of a chemokine gradient and chemotaxis in 
the lumen. This suggests that once a neutrophil starts to crawl in the lumen, it in effect becomes a 
“chemotaxing” cell. The “chemotaxing” cells undergo polarization, cytoskeletal reorganization, 
shape changes and rapid low-affinity crawling to move cell body towards the chemoattractant 
[25]. The regulation of cytoskeletal remodeling by LSP1 has been intensely investigated [58, 
60-63, 73]. The in vitro study by Hannigan et al. revealed the impacts of the defects on migration 
speed and chemotaxis in Lsp1−/− neutrophils in response to KC, and concluded that these were due 
to the abnormal morphologies in these cells, indicating that LSP1 was important for the 
modulation of F-actin bundle and the cell stability during chemotaxis [51]. As a result, the major 
functions of N-LSP1 appear to be the modulation of F-actin binding, cytoskeleton reorganization 
and cell motility towards the chemokine gradient. These findings appear to explain my in vivo 
data: the decreased velocity of crawling migration, crawling chemotaxis and migration in tissue 
and prolonged crawling time and transmigration time in Lsp1−/−→ Lsp1−/− mice can be rescued to 
some extent in WT→ Lsp1−/− mice. 
Similar responses to MIP-2- and KC-induced neutrophil recruitment in my study indicated that 
the role of LSP1 in MIP-2- and KC-elicited chemotaxis appears to be the same. Liu et al. showed 
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 that, in response to KC-in-gel, Lsp1−/− mice exhibited significantly decreased emigration in 
neutrophil recruitment and this impairment was also observed in WT→Lsp1−/− mice but not in 
Lsp1−/−→WT mice [46]. This is consistent with my data following both MIP-2- and KC-in-gel 
administration and demonstrated a dominant role for E-LSP1 in neutrophil emigration. In my 
study, I examined the role of LSP1 in further detailed steps of neutrophil recruitment and my data 
showed E-LSP1 had a role in chemokine-induced neutrophil intraluminal crawling, 
transendothelial migration and chemotaxis in extravascular tissue. My data also revealed that 
during intraluminal crawling in E-LSP1-deficient mice, neutrophils exhibited decreased velocity 
of chemotaxis, chemotaxis index and prolonged crawling time in response to MIP-2. One possible 
reason for the phenomenon could be the absence of an intravascular chemokine gradient, due to 
an inability of Lsp1−/− ECs to transport and present chemokines to neutrophils. By using intravital 
 
 
and confocal microscopy, Menezes et al. recently showed that in response to MIP-2-in-gel, a 
chemokine gradient formed intravascularly, and influenced intraluminal neutrophil crawling [5]. 
Chemokines were found to bind to the endothelial heparin sulfate (HS) chains to be immobilized 
on the luminal surface of endothelium. Thereafter, chemokines were transported from basolateral 
to apical of endothelium and finally transported to neutrophils via endothelial heparin sulfate 
proteoglycans (HSPGs) binding to L-selectins to induce the effective intraluminal crawling and 
chemotaxis in the lumen [5]. Many of the intracellular transportation processes are related to the 
functions of actin and F-actin may be involved in chemokine transportation. Because of LSP1 has 
F-actin binding sites and has an impact on F-actin functions, E-LSP1 may play an important role 
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on chemokine transportation. 
 
 
In this study, my data showed that during transendothelial migration,E-LSP1-deficient mice 
exhibited increased transmigration time and reduced transmigration cells in response to MIP-2. 
The failure of dome structure formation is one possible mechanism. Petri et al. provided evidence 
that some LSP1 in ECs is translocated to the cytoskeleton from the nucleus to induce dome 
structure formation, which is a subendothelial complex for neutrophil-endothelial cell interactions 
that is critical for neutrophil recruitment [74]. Another reasonable mechanism may be the 
impairment of endothelial retraction in E-LSP1-deficient mice. Studies by Liu et al. suggested 
that LSP1 may affect endothelial retraction to regulate vascular permeability and promote 
neutrophils transmigration [46]. As a result, E-LSP1 may be critical for dome structure formation 
and endothelial retraction during neutrophil transmigration. 
Neutrophil chemotaxis in extravasular tissue is, to a large extent, dependent on multiple 
functions of integrins, which affect adhesion, spreading, contractility and retraction [75]. My 
results demonstrated the important role of E-LSP1 in neutrophil chemotaxis in tissue and one 
possible mechanism for the role of LSP1 may involve the functions of integrins. It has been 
reported that after TEM, the phenotype and functions of neutrophils will change such as the 
transfer of membrane proteins from ECs to the migrating neutrophils [76]. During TEM, the 
endothelium forms dome structures to facilitate neutrophil migration [11] and LSP1 is important 
for dome structure formation [74]. Therefore, one possibility is that LSP1 involves in the changes 
of neutrophil phenotype and functions during TEM. Lee et al. recently demonstrated that the 
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extracellular matrix (ECM) protein lumican regulates neutrophil chemotaxis in tissue through 
regulating β2  integrins (especially Mac-1) directly and β1 integrins indirectly [77]. Interestingly, 
they demonstrated that lumican is expressed on endothelium but not on bone marrow or 
peripheral blood neutrophils. However, lumican exists on the surface of emigrated peritoneal 
neutrophils, indicating that neutrophils must acquire lumican during the migration across the 
endothelium in order to migrate effectively towards chemoattractant in the gradient in 
extravascular tissue [77]. As a result, the impairments of velocity of neutrophil chemotaxis and 
chemotaxis index in tissue after the transmigration across Lsp1−/− ECs in my data may be due to 
the disability of ECs to transfer endothelium proteins such as lumican to neutrophils, leading to 
the low affinity of integrins on the transmigrated neutrophils and the reduced chemotaxis of these 
neutrophils in tissue. 
 
 
 
7.2. MIP-2-induced neutrophil chemotaxis in tissue is dependent on p38 MAPK signaling 
pathway 
 
LSP1 has been shown to be a major substrate of the MK2 in the p38 MAPK signaling 
pathway [48]. MK2 and p38 MAPK were reported to be essential for neutrophil motility and 
chemotaxis in response to fMLP [53]. Cara et al. demonstrated that intravenous treatment with the 
p38 MAPK inhibitor SB203580 (20 mg/kg) for 30 min before the administration of KC-in-gel 
blocked about 70% of emigrating cells and inhibited neutrophil chemotaxis in tissue [39]. They 
also showed that 0.7 mM p38 MAPK inhibitor SKF86002 superfusion for 60 min after KC-in-gel 
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treatment restricted neutrophil chemotaxis in tissue, suggesting that KC-induced neutrophil 
recruitment is via the p38 MAPK pathway [39]. My data showed that both p38 MAPK inhibitors 
SB203580 and SKF86002 blocked MIP-2-induced neutrophil recruitment and chemotaxis in 
tissue, indicating MIP-2-induced neutrophil recruitment is also dependent on p38 
MAPK-activation. In addition, my data showed that E-LSP1 is critical for neutrophil chemotaxis 
in tissue and SKF86002 treatment inhibited the chemotaxis of neutrophils after their 
transendothelial migration. My data revealed that although the chemotaxis of Lsp1−/− neutrophils, 
after transmigration across WT ECs, were almost normal and LSP1-independent (Fig. 6.9), LSP1 
regulation of MIP-2-induced neutrophil recruitment and chemotaxis in tissue is completely 
dependent on p38 MAPK pathway, suggesting the existence of an LSP1-independent signaling 
mechanism in chemotaxing neutrophils in tissue that functions under the control of or 
downstream of p38 MAPK activity during their chemotaxis. 
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 8. Summary 
 
 
 
My first objective of this study was to determine the role of LSP1 in MIP-2- or 
 
 
KC-in-gel-induced neutrophil recruitment by using intravital microscopy in vivo. Mouse 
cremaster muscle treated with 0.5 µM MIP-2- or KC-in-gel for 90 min exhibited similar rolling 
velocity, rolling flux responses in WT mice and Lsp1−/− mice, but a lower adhesion and 
significantly decreased emigration in Lsp1−/− mice. Time-lapse video photography analysis 
 
 
revealed that LSP1 regulated neutrophil intraluminal crawling, transendothelial migration and 
chemotaxis in tissue. In addition, the recruitment responses to MIP-2 and KC were similar, 
suggesting that the two CXC chemokines may induce neutrophil recruitment via the same 
signaling pathway. 
To further understand the functional role of neutrophil LSP1 (N-LSP1) and endothelial LSP1 
(E-LSP1) in neutrophil recruitment, intravital video microscopy and time-lapse video 
photography were performed using four types of chimeric mice that we generated. Emigration in 
neutrophil recruitment was significantly inhibited in WT→Lsp1−/− mice as well as in 
Lsp1−/−→Lsp1−/− mice but not in Lsp1−/−→WT mice. The results suggested that N-LSP1 
 
 
promoted intraluminal crawling, transmigration and migration in tissue maybe by the modulation 
of cytoskeletal remodeling and that E-LSP1 played more important roles in MIP-2-induced 
neutrophil recruitment maybe through regulating the intravascular chemokine gradient, dome 
structure formation, ECs retraction and the integrin affinity of chemotaxing neutrophils in tissue. 
Finally, I examined the role of p38 MAPK signaling pathway in MIP-2-induced neutrophil 
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recruitment and found that LSP1 regulation of MIP-2-induced neutrophil emigration and 
chemotaxis in tissue is completely p38 MAPK pathway dependent and there exists a signaling 
mechanism that is important in the chemotaxing neutrophils, is downstream of or under the 
control of p38 MAPK and in parallel but independent of LSP1 signaling pathway for the 
neutrophil migration and chemotaxis in vivo. 
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 9. Conclusion 
 
 
 
In general, this study provides the first evidence that E-LSP1 appears to play a critical role in 
neutrophil directional migration both in the lumen and in extravascular tissue, especially for 
chemotaxis in tissue in response to MIP-2-in-gel-induced neutrophil recruitment. Additionally, 
blockade of p38 MAPK pathway locally or systematically inhibit neutrophil emigration and 
chemotaxis in tissue and this inhibitory effect is partially achieved through LSP1. 
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 10. Future studies 
 
 
 
Based on the experiments described in this thesis, the following studies are proposed. 
 
 
a.   To study the role of E-LSP1 in neutrophil-endothelial cell interactions and neutrophil 
transendothelial migration in vitro with in vitro transwell system 
b.  To identify the functional molecules which influence the chemotaxis of transmigrated 
neutrophils in Lsp1−/−→WT mice in tissue with flow cytometry. 
c.   To study LSP1-involved signaling mechanisms in vitro. 
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